Remy Gross is the CEO of RCP Companies, a boutique real estate company known for its creative development and value-add transactions. Remy also serves as the Vice President of Business Development & Technology Advancement at the Buck Institute for Research on Aging, the nation's first independent research facility focused on aging and chronic disease. Additionally, Remy is a board member at Napa Therapeutics and BHB Therapeutics, Ltd, and previously worked as the Head of Business Development at Serina Therapeutics. With a background in chemistry and management of technology, Remy has a strong track record in the biotechnology and real estate industries.
Sign up to view 5 direct reports
Get started